LISA MOORE: Open Payments
NPI 1689068751 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 52 payments from 12 companies in 2025. Trend: 2023 $867 · 2024 $417 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $216 |
| ABBVIE INC. | 18 | $209 |
| Alkermes, Inc. | 9 | $154 |
| Vanda Pharmaceuticals Inc. | 6 | $111 |
| Teva Pharmaceuticals USA, Inc. | 1 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Tris Pharma Inc | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, ARISTADA, UZEDY, HETLIOZ, CAPLYTA, Dyanavel XR, FANAPT.
Industry payments across NC — which companies pay providers there.
